{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:21:29Z","timestamp":1791300089969,"version":"4.1.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1784,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CNRS"},{"name":"Universit\u00e9 de la M\u00e9diterran\u00e9e"},{"name":"European Community","award":["HEALTH-2007-22918"],"award-info":[{"award-number":["HEALTH-2007-22918"]}]},{"name":"Fondo per gli Investimenti della Ricerca di Base 2003 (FIRB2003)"},{"name":"Ministero della Salute Progetto Strategico 2007"},{"name":"Progetti Finalizzati Ministero della Salute 2005\u20132006"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbadis.2009.08.001","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T08:23:41Z","timestamp":1250756621000},"page":"151-161","source":"Crossref","is-referenced-by-count":32,"title":["Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: From experimental models to neurodegenerative diseases"],"prefix":"10.1016","volume":"1802","author":[{"given":"Paolo","family":"Gubellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2009.08.001_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1523\/JNEUROSCI.07-07-02129.1987","article-title":"Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats","volume":"7","author":"Amalric","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00428200","article-title":"Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats","volume":"85","author":"Arnt","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbadis.2009.08.001_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2009.08.001_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","article-title":"Permanent human parkinsonism due to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): seven cases","volume":"35","author":"Ballard","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib10","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.expneurol.2009.01.010","article-title":"A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity","volume":"217","author":"Belcastro","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/jn.1994.72.2.507","article-title":"The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism","volume":"72","author":"Bergman","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1098\/rstb.2005.1765","article-title":"Ca2+ signals and death programmes in neurons","volume":"360","author":"Berliocchi","year":"2005","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1460-9568.1999.00627.x","article-title":"Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms","volume":"11","author":"Bezard","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","article-title":"Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study","volume":"15","author":"Bloch","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2009.08.001_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib18","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington's disease: an evidence-based review","volume":"12","author":"Bonelli","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2009.08.001_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.expneurol.2003.09.016","article-title":"Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons","volume":"185","author":"Bonsi","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev.biochem.66.1.717","article-title":"The ATP synthase \u2014 a splendid molecular machine","volume":"66","author":"Boyer","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","article-title":"Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates","volume":"8","author":"Brouillet","year":"1995","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib24","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib25","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2009.08.001_bib27","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/tx049867r","article-title":"Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease","volume":"17","author":"Caboni","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib28","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S1471-1931(00)00017-3","article-title":"Electrophysiology of dopamine in normal and denervated striatal neurons","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib29","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S1471-1931(00)00017-3","article-title":"Electrophysiology of dopamine in normal and denervated striatal neurons","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib30","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1523\/JNEUROSCI.21-14-05110.2001","article-title":"Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine","volume":"21","author":"Calabresi","year":"2001","journal-title":"J. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.bbadis.2009.08.001_bib31","first-page":"433","article-title":"Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease","volume":"116","author":"Calabresi","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2009.08.001_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/nbdi.2000.0379","article-title":"A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication","volume":"8","author":"Calabresi","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.08.001_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0968-0004(94)90071-X","article-title":"The cytochrome oxidase superfamily of redox-driven proton pumps","volume":"19","author":"Calhoun","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/mol.108.050781","article-title":"Suppression of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis","volume":"75","author":"Carbone","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia \u2014 implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.biochem.72.121801.161700","article-title":"Function and structure of complex II of the respiratory chain","volume":"72","author":"Cecchini","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.2001.7812","article-title":"Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese","volume":"172","author":"Centonze","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.expneurol.2006.07.009","article-title":"NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum","volume":"202","author":"Centonze","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.08.001_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/taap.2001.9245","article-title":"Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe\u2013S] containing enzymes","volume":"175","author":"Chen","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.amjmed.2004.03.032","article-title":"Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance","volume":"117","author":"Christine","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib45","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M708597200","article-title":"Complex I is the major site of mitochondrial superoxide production by paraquat","volume":"283","author":"Cocheme","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib46","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib47","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1523\/JNEUROSCI.1947-08.2008","article-title":"Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition","volume":"28","author":"Costa","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1146\/annurev.physiol.66.032102.150251","article-title":"The cytochrome bc1 complex: function in the context of structure","volume":"66","author":"Crofts","year":"2004","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/hmg\/ddg044","article-title":"Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death","volume":"12","author":"Darios","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.08.001_bib52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2009.08.001_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease","volume":"62","author":"de Rijk","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2009.08.001_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.64.1.20","article-title":"Circuits and circuit disorders of the basal ganglia","volume":"64","author":"DeLong","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib57","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neuro.2006.05.012","article-title":"Paraquat exposure as an etiological factor of Parkinson's disease","volume":"27","author":"Dinis-Oliveira","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1196\/annals.1306.009","article-title":"Manganese neurotoxicity","volume":"1012","author":"Dobson","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.10350","article-title":"p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism","volume":"52","author":"Duan","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1113\/jphysiol.2007.145409","article-title":"Ca2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity","volume":"585","author":"Duan","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib61","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1523\/JNEUROSCI.0302-06.2006","article-title":"Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo","volume":"26","author":"Escartin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib64","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1062236","article-title":"Structural biology. Controlling the caspases","volume":"294","author":"Fesik","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.08.001_bib66","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin\u2013proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib67","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0926-6917(95)90058-6","article-title":"Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese","volume":"293","author":"Galvani","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib69","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1523\/JNEUROSCI.22-06-02174.2002","article-title":"The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase\/c-Jun module","volume":"22","author":"Garcia","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0149-7634(98)00014-1","article-title":"Reaction time deficits and Parkinson's disease","volume":"22","author":"Gauntlett-Gilbert","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2009.08.001_bib71","first-page":"445","article-title":"Manganese and calcium transport in mitochondria: implications for manganese toxicity","volume":"20","author":"Gavin","year":"1999","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(98)00279-9","article-title":"Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine","volume":"351","author":"Glinka","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib73","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib74","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0092-8674(00)81728-6","article-title":"Apoptotic pathways: the roads to ruin","volume":"94","author":"Green","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib77","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.bbadis.2009.08.001_bib78","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S1353-8020(03)00023-3","article-title":"The rotenone model of Parkinson's disease: genes, environment and mitochondria","volume":"9","author":"Greenamyre","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2009.08.001_bib79","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archneur.1991.00530210109030","article-title":"N-methyl-d-aspartate antagonists in the treatment of Parkinson's disease","volume":"48","author":"Greenamyre","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib80","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","article-title":"Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants","volume":"100","author":"Greene","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0301-0082(96)00006-8","article-title":"Bioenergetics and glutamate excitotoxicity","volume":"48","author":"Greene","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib82","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1471-4159.1993.tb03634.x","article-title":"Inhibition of succinate dehydrogenase by malonic acid produces an \u201cexcitotoxic\u201d lesion in rat striatum","volume":"61","author":"Greene","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib83","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0306-4522(97)00389-8","article-title":"3-Nitropropionic acid exacerbates N-methyl-d-aspartate toxicity in striatal culture by multiple mechanisms","volume":"84","author":"Greene","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.08.001_bib84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib85","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuropharm.2003.11.021","article-title":"Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1\/PKC pathway","volume":"46","author":"Gubellini","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib86","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1460-9568.2006.05047.x","article-title":"Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission","volume":"24","author":"Gubellini","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib87","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","article-title":"Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases","volume":"74","author":"Gubellini","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2009.06.003","article-title":"Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior","volume":"89","author":"Gubellini","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/15216540152846000","article-title":"Uptake of calcium by mitochondria: transport and possible function","volume":"52","author":"Gunter","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2009.08.001_bib91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1306.010","article-title":"Oxidative basis of manganese neurotoxicity","volume":"1012","author":"HaMai","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00691103","article-title":"Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage","volume":"72","author":"Hamilton","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib93","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/0264-6021:3530411","article-title":"Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space","volume":"353","author":"Han","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2009.08.001_bib94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00194305","article-title":"The epidemiology of Huntington's disease","volume":"89","author":"Harper","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbadis.2009.08.001_bib95","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1471-1931(00)00021-5","article-title":"Metabolic effects of nigrostriatal denervation in basal ganglia","volume":"23","author":"Hirsch","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib96","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","article-title":"Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse","volume":"12","author":"Itier","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl 2","key":"10.1016\/j.bbadis.2009.08.001_bib97","first-page":"S16","article-title":"Functional models of Parkinson's disease: a valuable tool in the development of novel therapies","volume":"64","author":"Jenner","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib98","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbrc.2008.10.104","article-title":"PINK1 controls mitochondrial localization of Parkin through direct phosphorylation","volume":"377","author":"Kim","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2009.08.001_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0301-0082(94)90021-3","article-title":"Monoamine oxidase: distribution in the cat brain studied by enzyme- and immunohistochemistry: recent progress","volume":"42","author":"Kitahama","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib101","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib102","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib103","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates parkin","volume":"11","author":"LaVoie","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib104","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bcp.2008.08.006","article-title":"Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta","volume":"76","author":"Lee","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.bbabio.2006.05.007","article-title":"Mitochondrial complex I: structural and functional aspects","volume":"1757","author":"Lenaz","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.08.001_bib106","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bbadis.2009.08.001_bib107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0306-4522(96)00409-5","article-title":"Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states","volume":"76","author":"Levy","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.08.001_bib108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib109","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib111","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib112","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib113","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1471-4159.2003.01759.x","article-title":"Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism","volume":"85","author":"Maccarrone","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib114","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.08.001_bib115","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: more than just a powerhouse","volume":"16","author":"McBride","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib116","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(97)00594-0","article-title":"Methylmalonate toxicity in primary neuronal cultures","volume":"86","author":"McLaughlin","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.08.001_bib117","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/brain\/awh616","article-title":"Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations","volume":"128","author":"Meissner","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2009.08.001_bib118","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson's disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2009.08.001_bib119","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res."},{"issue":"Suppl 2","key":"10.1016\/j.bbadis.2009.08.001_bib120","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism. Relat Disord."},{"key":"10.1016\/j.bbadis.2009.08.001_bib121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0301-0082(97)00055-5","article-title":"Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging","volume":"54","author":"Michaelis","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib122","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/213137a0","article-title":"Chemiosmotic hypothesis of oxidative phosphorylation","volume":"213","author":"Mitchell","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.08.001_bib124","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1073\/pnas.89.9.3859","article-title":"Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"89","author":"Moratalla","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2003.11.021","article-title":"Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease","volume":"15","author":"Napolitano","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.08.001_bib126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neulet.2007.09.056","article-title":"NF-kB\/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease","volume":"434","author":"Napolitano","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2009.08.001_bib127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-4173(82)90013-1","article-title":"Mitochondrial calcium transport","volume":"683","author":"Nicholls","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.08.001_bib128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0005-2728(98)00123-6","article-title":"Mitochondria and neuronal glutamate excitotoxicity","volume":"1366","author":"Nicholls","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.08.001_bib129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","article-title":"Mitochondria and neuronal survival","volume":"80","author":"Nicholls","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2009.08.001_bib130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0166-2236(99)01534-9","article-title":"Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts","volume":"23","author":"Nicholls","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib131","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib132","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuint.2007.02.008","article-title":"The mitochondrial permeability transition in neurologic disease","volume":"50","author":"Norenberg","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2009.08.001_bib133","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease \u2014 2007","volume":"17","author":"Olanow","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2009.08.001_bib134","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.neuroscience.2006.05.039","article-title":"Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease","volume":"141","author":"Ossowska","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.08.001_bib135","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1460-9568.2005.04301.x","article-title":"A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?","volume":"22","author":"Ossowska","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib136","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib137","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib138","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib139","doi-asserted-by":"crossref","first-page":"32626","DOI":"10.1074\/jbc.M404596200","article-title":"The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway","volume":"279","author":"Peng","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib140","doi-asserted-by":"crossref","first-page":"29194","DOI":"10.1074\/jbc.M500984200","article-title":"Superoxide dismutase\/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease","volume":"280","author":"Peng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib141","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of parkinsonism","volume":"102","author":"Perez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib142","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib143","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib144","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/brain\/awh190","article-title":"Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism","volume":"127","author":"Picconi","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2009.08.001_bib145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2005.10.009","article-title":"Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons","volume":"22","author":"Picconi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.08.001_bib146","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awf269","article-title":"Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment","volume":"125","author":"Picconi","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2009.08.001_bib147","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tcb.2007.07.011","article-title":"Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics","volume":"17","author":"Pizzo","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib148","first-page":"308","article-title":"Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice","volume":"140","author":"Porter","year":"1963","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2009.08.001_bib149","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2009.08.001_bib151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6123(08)61973-1","article-title":"Selective neuronal vulnerability: morphological and molecular characteristics","volume":"63","author":"Pulsinelli","year":"1985","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.bbadis.2009.08.001_bib152","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib153","first-page":"137","article-title":"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease","volume":"50","author":"Roitberg","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbadis.2009.08.001_bib154","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2007.07.022","article-title":"Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats","volume":"208","author":"Rojo","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib156","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2009.08.001_bib157","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2009.08.001_bib158","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mcn.2003.09.013","article-title":"Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease","volume":"25","author":"Saulle","year":"2004","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib159","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib160","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib161","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01345235","article-title":"Dopamine\u2013glutamate interactions in the basal ganglia","volume":"14","author":"Schmidt","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2009.08.001_bib162","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib163","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/tx980036t","article-title":"Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity","volume":"11","author":"Shen","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1987.tb03384.x","article-title":"Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"49","author":"Singer","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0300-483X(88)90169-2","article-title":"Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium","volume":"49","author":"Singer","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib166","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2009.08.001_bib167","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.08.001_bib168","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuron.2006.05.003","article-title":"Parkin blushed by PINK1","volume":"50","author":"Tan","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2009.08.001_bib169","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2007.06.008","article-title":"Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid","volume":"207","author":"Tozzi","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/B:NERE.0000014827.94562.4b","article-title":"Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease","volume":"29","author":"Tretter","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2009.08.001_bib171","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0300-483X(88)90037-6","article-title":"The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"49","author":"Trevor","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2009.08.001_bib172","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","article-title":"Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?","volume":"19","author":"Trotti","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib173","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1523\/JNEUROSCI.21-16-06430.2001","article-title":"Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions","volume":"21","author":"Tseng","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib174","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.bbabio.2006.03.017","article-title":"Mitochondrial membrane permeability transition and cell death","volume":"1757","author":"Tsujimoto","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.08.001_bib175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10495-006-0525-7","article-title":"Role of the mitochondrial membrane permeability transition in cell death","volume":"12","author":"Tsujimoto","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbadis.2009.08.001_bib176","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2009.08.001_bib177","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib178","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2009.08.001_bib179","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.08.001_bib180","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib181","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","article-title":"Expression pattern of apoptosis-related markers in Huntington's disease","volume":"109","author":"Vis","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib182","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.0305-1846.2001.00305.x","article-title":"The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum","volume":"27","author":"Vis","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib183","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","article-title":"Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease","volume":"21","author":"Viswanath","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib184","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.08.001_bib185","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1093\/hmg\/ddi413","article-title":"Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function","volume":"14","author":"Wang","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.08.001_bib186","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0959-4388(96)80024-9","article-title":"Functional and pathophysiological models of the basal ganglia","volume":"6","author":"Wichmann","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbadis.2009.08.001_bib187","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1042-3680(18)30261-4","article-title":"Models of basal ganglia function and pathophysiology of movement disorders","volume":"9","author":"Wichmann","year":"1998","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.bbadis.2009.08.001_bib188","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2009.08.001_bib189","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1471-4159.1994.63051772.x","article-title":"3-Nitropropionic acid toxicity in the striatum","volume":"63","author":"Wullner","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.08.001_bib190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.08.001_bib191","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1073\/pnas.0602493103","article-title":"Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.08.001_bib192","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/WNR.0b013e32831c50df","article-title":"Molecular basis of Parkinson's disease","volume":"20","author":"Yang","year":"2009","journal-title":"Neuroreport"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T20:09:11Z","timestamp":1739304551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443909001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":192,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0925443909001689"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2009.08.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}